Considering this information, we propose the hypothesis that the downregulation of circFAM13B in MB may upregulate IGF2BP1 expression levels and, thus, promote tumor growth through deregulation of the MYC and FSCN1 oncogenes. This evidence concerns the gene IGF2BP1 and neoplasm.